Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

923 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Safety of percutaneous ethanol injection as neoadjuvant therapy for hepatocellular carcinoma in waiting list liver transplant candidates.
Castroagudín JF, Delgado M, Villanueva A, Bustamante M, Martínez J, Otero E, Tomé S, Martínez SM, Segade FR, Conde R, Dominguez-Muñoz E, Varo E. Castroagudín JF, et al. Among authors: villanueva a. Transplant Proc. 2005 Nov;37(9):3871-3. doi: 10.1016/j.transproceed.2005.09.168. Transplant Proc. 2005. PMID: 16386568
A molecular signature to discriminate dysplastic nodules from early hepatocellular carcinoma in HCV cirrhosis.
Llovet JM, Chen Y, Wurmbach E, Roayaie S, Fiel MI, Schwartz M, Thung SN, Khitrov G, Zhang W, Villanueva A, Battiston C, Mazzaferro V, Bruix J, Waxman S, Friedman SL. Llovet JM, et al. Among authors: villanueva a. Gastroenterology. 2006 Dec;131(6):1758-67. doi: 10.1053/j.gastro.2006.09.014. Epub 2006 Sep 19. Gastroenterology. 2006. PMID: 17087938
Ras promotes growth by alternative splicing-mediated inactivation of the KLF6 tumor suppressor in hepatocellular carcinoma.
Yea S, Narla G, Zhao X, Garg R, Tal-Kremer S, Hod E, Villanueva A, Loke J, Tarocchi M, Akita K, Shirasawa S, Sasazuki T, Martignetti JA, Llovet JM, Friedman SL. Yea S, et al. Among authors: villanueva a. Gastroenterology. 2008 May;134(5):1521-31. doi: 10.1053/j.gastro.2008.02.015. Epub 2008 Feb 13. Gastroenterology. 2008. PMID: 18471523 Free PMC article.
Pivotal role of mTOR signaling in hepatocellular carcinoma.
Villanueva A, Chiang DY, Newell P, Peix J, Thung S, Alsinet C, Tovar V, Roayaie S, Minguez B, Sole M, Battiston C, Van Laarhoven S, Fiel MI, Di Feo A, Hoshida Y, Yea S, Toffanin S, Ramos A, Martignetti JA, Mazzaferro V, Bruix J, Waxman S, Schwartz M, Meyerson M, Friedman SL, Llovet JM. Villanueva A, et al. Gastroenterology. 2008 Dec;135(6):1972-83, 1983.e1-11. doi: 10.1053/j.gastro.2008.08.008. Epub 2008 Aug 20. Gastroenterology. 2008. PMID: 18929564 Free PMC article.
Pathogenesis of hepatocellular carcinoma and molecular therapies.
Mínguez B, Tovar V, Chiang D, Villanueva A, Llovet JM. Mínguez B, et al. Among authors: villanueva a. Curr Opin Gastroenterol. 2009 May;25(3):186-94. doi: 10.1097/MOG.0b013e32832962a1. Curr Opin Gastroenterol. 2009. PMID: 19387255 Review.
New strategies in hepatocellular carcinoma: genomic prognostic markers.
Villanueva A, Hoshida Y, Toffanin S, Lachenmayer A, Alsinet C, Savic R, Cornella H, Llovet JM. Villanueva A, et al. Clin Cancer Res. 2010 Oct 1;16(19):4688-94. doi: 10.1158/1078-0432.CCR-09-1811. Epub 2010 Aug 16. Clin Cancer Res. 2010. PMID: 20713493 Free PMC article.
Inherited hepatocellular carcinoma.
Villanueva A, Newell P, Hoshida Y. Villanueva A, et al. Best Pract Res Clin Gastroenterol. 2010 Oct;24(5):725-34. doi: 10.1016/j.bpg.2010.07.008. Best Pract Res Clin Gastroenterol. 2010. PMID: 20955973 Review.
923 results